Blackstone Group »

Intra Cellular Therapies shares owned by Blackstone Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Blackstone Group

Quarter filed Position value Share count Share price at filing
2025-03-31 $819k 6.2k 131.92

Top funds holding Intra Cellular Therapies